Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rocmans

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 1, 1994
Pretreatment minimal staging for non-small cell lung cancer: an updated consensus reportP Goldstraw, P Rocmans, D Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinomaJ Klastersky, J P Sculier, P Ravez, et al.
Presse Medicale (Paris, France : 1983)|May 3, 1986
[Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results]J P Sculier, J Klastersky, N Nguyen, et al.
Thorax|October 1, 1987
Increased plasma motilin concentrations in small cell carcinoma of the lungA Noseda, T L Peeters, M Delhaye, et al.
Acta Chirurgica Belgica|October 1, 1971
Total transplantation of the lungs. Experimental proceduresP Vanderhoeft, G Primo, P Rocmans, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.
Journal De Radiologie|March 1, 1989
[Neoplastic invasion of the pulmonary arteries. Evaluation by MRI. Preliminary experience]P A Gevenois, D Tack, G Van den Bossche, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancerR Feld, R Abratt, S Graziano, et al.
Histology and Histopathology|May 16, 2000
Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesionsN Nagy, C Decaestecker, X Dong, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerJ P Sculier, J Klastersky, D Becquart, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|November 1, 1994
Pretreatment minimal staging for non-small cell lung cancer: an updated consensus reportP Goldstraw, P Rocmans, D Ball, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1986
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinomaJ Klastersky, J P Sculier, P Ravez, et al.
Presse Medicale (Paris, France : 1983)|May 3, 1986
[Polychemotherapy of undifferentiated small cell bronchial cancer. Long-term results]J P Sculier, J Klastersky, N Nguyen, et al.
Thorax|October 1, 1987
Increased plasma motilin concentrations in small cell carcinoma of the lungA Noseda, T L Peeters, M Delhaye, et al.
Acta Chirurgica Belgica|October 1, 1971
Total transplantation of the lungs. Experimental proceduresP Vanderhoeft, G Primo, P Rocmans, et al.
Cancer Treatment Reports|June 1, 1986
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium)J P Sculier, J Klastersky, J P Dumont, et al.
Journal De Radiologie|March 1, 1989
[Neoplastic invasion of the pulmonary arteries. Evaluation by MRI. Preliminary experience]P A Gevenois, D Tack, G Van den Bossche, et al.
Lung Cancer (Amsterdam, Netherlands)|June 1, 1997
Pretreatment minimal staging and prognostic factors for non-small cell lung cancerR Feld, R Abratt, S Graziano, et al.
Histology and Histopathology|May 16, 2000
Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesionsN Nagy, C Decaestecker, X Dong, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancerJ P Sculier, J Klastersky, D Becquart, et al.
Pageof 9